BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 24389642)

  • 1. Hypoxia and cancer cell metabolism.
    Huang D; Li C; Zhang H
    Acta Biochim Biophys Sin (Shanghai); 2014 Mar; 46(3):214-9. PubMed ID: 24389642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia-mediated drug resistance: novel insights on the functional interaction of HIFs and cell death pathways.
    Rohwer N; Cramer T
    Drug Resist Updat; 2011 Jun; 14(3):191-201. PubMed ID: 21466972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the hypoxia-inducible factor (HIF) pathway in cancer.
    Poon E; Harris AL; Ashcroft M
    Expert Rev Mol Med; 2009 Aug; 11():e26. PubMed ID: 19709449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eicosanoids and other lipid mediators and the tumor hypoxic microenvironment.
    Krishnamoorthy S; Honn KV
    Cancer Metastasis Rev; 2011 Dec; 30(3-4):613-8. PubMed ID: 22042480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent agents targeting HIF-1α for cancer therapy.
    Hu Y; Liu J; Huang H
    J Cell Biochem; 2013 Mar; 114(3):498-509. PubMed ID: 22961911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting hypoxia, HIF-1, and tumor glucose metabolism to improve radiotherapy efficacy.
    Meijer TW; Kaanders JH; Span PN; Bussink J
    Clin Cancer Res; 2012 Oct; 18(20):5585-94. PubMed ID: 23071360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia-inducible factor-1 as a therapeutic target in cancer.
    Tang CM; Yu J
    J Gastroenterol Hepatol; 2013 Mar; 28(3):401-5. PubMed ID: 23173651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ERRα augments HIF-1 signalling by directly interacting with HIF-1α in normoxic and hypoxic prostate cancer cells.
    Zou C; Yu S; Xu Z; Wu D; Ng CF; Yao X; Yew DT; Vanacker JM; Chan FL
    J Pathol; 2014 May; 233(1):61-73. PubMed ID: 24425001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIF: a master regulator of nutrient availability and metabolic cross-talk in the tumor microenvironment.
    Missiaen R; Lesner NP; Simon MC
    EMBO J; 2023 Mar; 42(6):e112067. PubMed ID: 36808622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting hypoxia cell signaling for cancer therapy.
    Melillo G
    Cancer Metastasis Rev; 2007 Jun; 26(2):341-52. PubMed ID: 17415529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia, cancer metabolism and the therapeutic benefit of targeting lactate/H(+) symporters.
    Marchiq I; Pouysségur J
    J Mol Med (Berl); 2016 Feb; 94(2):155-71. PubMed ID: 26099350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carrot and stick: HIF-alpha engages c-Myc in hypoxic adaptation.
    Huang LE
    Cell Death Differ; 2008 Apr; 15(4):672-7. PubMed ID: 18188166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of hypoxia in the hallmarks of human cancer.
    Ruan K; Song G; Ouyang G
    J Cell Biochem; 2009 Aug; 107(6):1053-62. PubMed ID: 19479945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of hypoxia-inducible factor-1alpha as a cancer therapy target.
    Patiar S; Harris AL
    Endocr Relat Cancer; 2006 Dec; 13 Suppl 1():S61-75. PubMed ID: 17259560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular redox status regulates hypoxia inducible factor-1 activity. Role in tumour development.
    Martínez-Sánchez G; Giuliani A
    J Exp Clin Cancer Res; 2007 Mar; 26(1):39-50. PubMed ID: 17550131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia-inducible factor 1 and breast cancer metastasis.
    Liu ZJ; Semenza GL; Zhang HF
    J Zhejiang Univ Sci B; 2015 Jan; 16(1):32-43. PubMed ID: 25559953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does endogenous fatty acid metabolism allow cancer cells to sense hypoxia and mediate hypoxic vasodilatation? Characterization of a novel molecular connection between fatty acid synthase (FAS) and hypoxia-inducible factor-1alpha (HIF-1alpha)-related expression of vascular endothelial growth factor (VEGF) in cancer cells overexpressing her-2/neu oncogene.
    Menendez JA; Vellon L; Oza BP; Lupu R
    J Cell Biochem; 2005 Apr; 94(5):857-63. PubMed ID: 15669079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia: Intriguing Feature in Cancer Cell Biology.
    Chowdhury M; Das PK
    ChemMedChem; 2024 May; 19(9):e202300551. PubMed ID: 38328976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of the breast cancer stem cell phenotype by hypoxia-inducible factors.
    Semenza GL
    Clin Sci (Lond); 2015 Dec; 129(12):1037-45. PubMed ID: 26405042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Akt/hypoxia-inducible factor-1alpha/platelet-derived growth factor-BB autocrine loop mediates hypoxia-induced chemoresistance in liver cancer cells and tumorigenic hepatic progenitor cells.
    Lau CK; Yang ZF; Ho DW; Ng MN; Yeoh GC; Poon RT; Fan ST
    Clin Cancer Res; 2009 May; 15(10):3462-71. PubMed ID: 19447872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.